| Dr Raymond E O'keefe, MD | |
|
2241 Bush River Rd, Columbia, SC 29210-5626 | |
| (803) 731-9600 | |
| (803) 731-0297 |
| Full Name | Dr Raymond E O'keefe |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 2241 Bush River Rd, Columbia, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225149925 | NPI | - | NPPES |
| 095505 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 9550 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Raymond E O'keefe, MD 2241 Bush River Rd, Columbia, SC 29210-5626 Ph: (803) 731-9600 | Dr Raymond E O'keefe, MD 2241 Bush River Rd, Columbia, SC 29210-5626 Ph: (803) 731-9600 |
News Archive
In patients who experienced an acute coronary syndrome (ACS) event (such as heart attack or unstable angina), use of the drug darapladib to inhibit the enzyme lipoprotein-associated phospholipase A2 (believed to play a role in the development of atherosclerosis) did not reduce the risk of recurrent major coronary events, according to a study published by JAMA.
Increasing the activity of two enzymes better known for their role in oxidative stress metabolism turns normally relaxed mice into "Nervous Nellies," according to research conducted at the Salk Institute for Biological Studies and reported in the early online edition of Nature.
Diabetes, obesity and nonalcoholic fatty liver disease (NAFLD) are all common diseases that can lead to serious health implications.
Norgine and Arc Medical Design Ltd. today announced a partnership that will see Norgine commercialising and distributing ENDOCUFF VISION, a Class 1 sterile medical device used in colonoscopy, across a number of major European markets, Australia and New Zealand. Norgine's first launch of ENDOCUFF VISION will take place in the UK Q2 2015.
Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, today announced the publication of breakthrough new research in the Proceedings of the National Academy of Sciences (USA). The discovery, centered on the epigenetic enzyme EZH2, illuminates a clear path for the translation of basic science into targeted therapies for the safe and effective treatment of specific forms of human lymphomas.
› Verified 2 days ago
Allison L Cashman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3600 Forest Dr Ste 400, Columbia, SC 29204 Phone: 803-779-7316 Fax: 803-343-2538 | |
Dr. Edward Shmunes, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3701 Northshore Rd, Columbia, SC 29206 Phone: 803-787-6314 | |
Dr. John Andrew Mouzakis, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3600 Forest Dr Ste 400, Columbia, SC 29204 Phone: 803-779-7316 Fax: 803-343-2538 | |
Dr. Ann Harriott Fisher Ervin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1706 St. Julians Place, Columbia, SC 29204 Phone: 803-771-7506 Fax: 803-771-9455 | |
Patricia A Mcclerklin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 112 Doctors Cir, Columbia, SC 29203 Phone: 803-771-9163 Fax: 803-771-7383 | |
Dr. Jing W Zhang, M.D., PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1706 Saint Julian Pl, Columbia, SC 29204 Phone: 803-771-7506 Fax: 803-771-9455 | |
Dr. Charles Davis, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 6439 Garners Ferry Rd, Columbia, SC 29209 Phone: 803-776-4000 |